Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Sales: 2009-2025

Historic Return on Sales for Amicus Therapeutics (FOLD) over the last 14 years, with Sep 2025 value amounting to -0.02%.

  • Amicus Therapeutics' Return on Sales rose 19.00% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year increase of 19.00%. This contributed to the annual value of -0.11% for FY2024, which is 27.00% up from last year.
  • Latest data reveals that Amicus Therapeutics reported Return on Sales of -0.02% as of Q3 2025, which was up 64.79% from -0.07% recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Return on Sales ranged from a high of -0.02% in Q3 2025 and a low of -0.95% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was -0.26% (2024), whereas its average is -0.28%.
  • Data for Amicus Therapeutics' Return on Sales shows a peak YoY surged of 61bps (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Amicus Therapeutics' Return on Sales stood at -0.82% in 2021, then rose by 10bps to -0.72% in 2022, then surged by 34bps to -0.38% in 2023, then increased by 27bps to -0.11% in 2024, then grew by 19bps to -0.02% in 2025.
  • Its last three reported values are -0.02% in Q3 2025, -0.07% for Q2 2025, and -0.05% during Q1 2025.